Thymosin Beta-4 (TB4)

Source / Derivation:

Thymosin Beta-4 (TB4) is a naturally occurring peptide present in human tissues, including blood cells and connective tissue. It plays a critical role in cell migration, angiogenesis, and tissue regeneration, contributing to the repair and maintenance of musculoskeletal and epithelial structures.

Thymosin Beta-4 (TB4)

Mechanism of Action:

TB4 regulates actin cytoskeleton dynamics, promotes endothelial and fibroblast proliferation, and facilitates cell migration to sites of tissue injury. It also modulates inflammatory responses, supporting balanced tissue remodeling and accelerated healing.

Clinical Relevance & Potential Outcomes:

Preclinical and clinical studies indicate TB4 may support healing of muscles, tendons, ligaments, and epithelial tissues, improving structural integrity and functional recovery. Evidence also suggests potential benefits in reducing inflammation and enhancing vascularization in injured or compromised tissues.

Intended Clinical Application:

TB4 may be considered for patients requiring enhanced soft-tissue repair, post-injury musculoskeletal rehabilitation, surgical recovery, or accelerated healing of chronic or acute injuries.

Formulation & Quality Specifications:

Delivered as a liquid prefilled pen
Purity: >98% (HPLC-validated)
Storage: 2–8 °C (refrigerated)
Documentation: Full CoA and MSDS available

Concentration:

Frequency:

Dosage (pen clicks):

Duration:

Notes:

10 mg/ml, total 3 ml, total 30 mg

Daily

1 month

A peptide known for its role in tissue regeneration, wound healing, and immune modulation.